Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 22, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility, specifically detailing a change in share interests in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding insider trading activity rather than a financial performance report.
Material Changes
The material change reported is a transaction by Ms. C Thomas, a Person Discharging Managerial Responsibility. On August 22, 2008, she sold 5,641 Ordinary shares of 25p each at a price of £12.44 per share. The company was advised of this transaction on the same date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share sale transaction.
Key Facts for Investor Verification
- Transaction Date: August 22, 2008
- Individual: Ms. C Thomas (Person Discharging Managerial Responsibility)
- Action: Sale of 5,641 Ordinary shares
- Price: £12.44 per share
- Regulatory Basis: Disclosure and Transparency Rule 3.1.4R(1)(a)